2021 Global Sunitinib Malate Market Report: The market will reach US$160.8 million by 2027-the US market is estimated to be US$19.7 million, while the Chinese market is expected to grow at a compound annual growth rate of 12.9%-ResearchAndMarkets.com


This “Sunitinib Malate-Global Market Trajectory and Analysis” Report has been added to ResearchAndMarkets.com provide.

By 2027, the global sunitinib malate market will reach US$160.8 million

During the COVID-19 crisis, the global market for sunitinib malate is estimated to be US$66.8 million in 2020, and is expected to reach a revised US$160.8 million by 2027, at a compound annual rate of 13.4% during 2020-2027. The growth rate grows.

The US market is estimated at $19.7 million, while China is expected to grow at a compound annual growth rate of 12.9%

The U.S. sunitinib malate market is estimated at USD 19.7 million in 2020. China is the world’s second largest economy, and the market size is expected to reach 28.1 million US dollars by 2027, with a compound annual growth rate of 12.9%. The analysis period is from 2020 to 2027.

Other notable geographic markets include Japan and Canada, which are expected to grow by 11.8% and 11.4% respectively during 2020-2027. In Europe, Germany is expected to grow at a compound annual growth rate of approximately 9.8%.

Key topics covered:

1. Methodology

2. Executive Summary

1. Market overview

  • Influencer market insights

  • World market trajectory

  • The impact of Covid-19 and the imminent global recession

2. Focus on selected players (44 selected in total):

  • Active Biotech

  • Astellas Pharmaceuticals

  • AstraZeneca

  • Bristol-Myers Squibb

  • Dengrui

  • Endo Pharmaceutical Co., Ltd.

  • Ferring Pharmaceuticals

  • Probiotics

  • Pfizer

  • Takeda Pharmaceutical Co., Ltd.

  • Teva Pharmaceutical Industry Co., Ltd.

  • TOLMAR Pharmaceutical Company

3. Market trends and driving factors

4. Global market perspective

  • World current and future analysis of sunitinib malate by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific and other world markets-Annual sales in USD and compound years from 2020 to 2027 Independent analysis of growth rate percentage

  • A review of the world history of sunitinib malate by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific and other markets in the world-Annual sales in US dollars and compound annual growth from 2012 to 2019 Independent analysis of rate percentage

  • Sunitinib Malate 15-year World Outlook by Geographic Region-Percentage of Market Sales Value Segmentation in the U.S., Canada, Japan, China, Europe, Asia Pacific, and Rest of the World in 2012, 2020, and 2027

3. Regional market analysis

Fourth, the competition

  • Total number of company profiles: 44

For more information about this report, please visit https://www.researchandmarkets.com/r/av0vrl



Source link

Recommended For You

About the Author: Brand Story